High Dose Chemotherapy and Autologous Transplant for Breast Cancer
High Dose Chemotherapy and Peripheral Blood Progenitor Cell Rescue for Patients With Breast Cancer
1 other identifier
interventional
N/A
1 country
1
Brief Summary
To determine survival outcomes for patients with chemosensitive brest cancer after treatment with high dose chemotherapy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Completion
Last participant's last visit for all outcomes
March 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 14, 2005
CompletedFirst Posted
Study publicly available on registry
September 16, 2005
CompletedJuly 11, 2007
July 1, 2007
September 14, 2005
July 10, 2007
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Survival
Interventions
Eligibility Criteria
You may qualify if:
- Stage II, III or IV breast cancer
- chemosensitive
- adequate organ function
You may not qualify if:
- prior transplant,
- life threatening disease
- brain metastases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford University Cancer Center
Stanford, California, 94305, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ginna Laport, MD
Stanford University
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 14, 2005
First Posted
September 16, 2005
Study Completion
March 1, 2005
Last Updated
July 11, 2007
Record last verified: 2007-07